Comparing the amount of donor skin required for burn victim treatments, studies have shown the RECELL system has a 97.5% reduction in the donor’s skin requirement for second-degree burns, and a 32% reduction for third-degree.
The company reports that RECELL has been used more than 8,000 times to date commercially, with no observed safety signals. Doctors reportedly found that using RECELL was significantly less painful for patients while providing results faster.
Avita Medical is a global operation with RECELL approved in the United States, Europe, China, and Australia. They are currently in the process of being approved to market in Japan, with JPMDA approval expected in 2020. The company has proactively secured a collaboration with COSMOTEC to market and distribute RECELL treatments in Japan after approval.
In addition, RECELL is being researched to treat paediatric scalds and soft tissue reconstruction by the end of Q1 2020, and repigmentation for vitiligo by Q3 2020. Completing these milestones provides Avita Medical with avenues into markets beyond burn treatments. The company currently values the opportunities of these markets at over US$1.1 billion.
A little behind schedule... there’s a schedule though. Billion dollar opportunity schedule.
The big picture. Forum for long holder, page-3
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.99 |
Change
0.330(12.4%) |
Mkt cap ! $185.9M | |||
| Open | High | Low | Value | Volume |
| $3.04 | $3.17 | $2.95 | $5.283M | 1.752M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5991 | $2.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.00 | 12281 | 1 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.99 |
Change
0.330 ( 12.2 %) |
||||
| Open | High | Low | Volume | ||
| $3.10 | $3.10 | $2.95 | 117225 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| AVH (ASX) Chart |